Valeant's Debt In 2020 'May Be Too High A Hurdle'
June 08, 2016 at 08:39 AM EDT
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) filed its 10-Q for 1Q16 on July 7. Wells Fargo’s David Maris maintained an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.